Cargando…
Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
Autores principales: | Brown, Christine E, Starr, Renate, Naranjo, Araceli, Aguilar, Brenda, Chang, Wen-Chung, Ostberg, Julie, Warden, Charles, Yuan, Yate-Ching, D'Apuzzo, Massimo, Barish, Michael E, Badie, Behnam, Jensen, Michael C, Forman, Stephen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990334/ http://dx.doi.org/10.1186/2051-1426-1-S1-P2 |
Ejemplares similares
-
Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
por: Brown, Christine E, et al.
Publicado: (2015) -
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
por: Brown, Christine E., et al.
Publicado: (2013) -
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma
por: Barish, Michael E., et al.
Publicado: (2022) -
Pituitary metastasis: a rare condition
por: Javanbakht, Aida, et al.
Publicado: (2018) -
Chimeric antigen receptors (CARs) incorporating mutations in the IgG4 Fc spacer region to eliminate Fc receptor recognition results in improved CAR T cell persistence and anti-tumor efficacy
por: Jonnalagadda, Mahesh, et al.
Publicado: (2013)